Overview: HbC TestIntroduction: The HbC Test tests for hemoglobin C to diagnose HbC disease, causing mild anemia or spleen enlargement, helping manage blood disorders. Affecting 1 in 1,000 people of African descent, HbC disease poses diagnostic challenges due to mild symptoms. Following 2023 American Society of Hematology (ASH) guidelines, it uses electrophoresis for high accuracy, supporting hematology screening. This test is essential for diagnosis, monitoring, and improving outcomes in hematology.
Other Names: Hemoglobin C Test, HbC Disease Assay.
FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic reliability.
Historical Milestone: Hemoglobin variant testing began in the 1950s with research by Itano, who identified HbC. Electrophoresis advancements in the 1970s by Helena Laboratories improved detection, surpassing earlier solubility tests.
Purpose: Detects hemoglobin C to diagnose HbC disease, guides blood management, and evaluates patients with anemia, aiming to prevent complications.
Test Parameters: Hemoglobin C presence
Pretest Condition: No special preparation required. Collect whole blood. Report history of blood disorders.
Specimen: Whole Blood (EDTA, 2-5 mL); 4 mL whole blood in EDTA tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 1 week
Sample Stability at Frozen: 1 month
Medical History: Document mild anemia or spleen enlargement. Include current medications or transfusion history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., splenomegaly), and sample collection risks.
Procedural Considerations: Uses electrophoresis to detect HbC, requiring labs with electrophoresis equipment. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample hemolysis or degradation can affect results. Medications may not affect results but require correlation.
Clinical Significance: Positive HbC confirms disease, guiding management. Early monitoring might prevent complications, while untreated cases lead to worsening. Normal results may require other hemoglobin tests.
Specialist Consultation: Consult a hematologist for interpretation.
Additional Supporting Tests: Complete blood count, hemoglobin electrophoresis, or genetic panel to confirm diagnosis.
Test Limitations: Specific to HbC; correlation with symptoms needed. False negatives possible with mixed variants.
References: ASH Guidelines, 2023; Blood, Itano HA, 2022.
